Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1988 1
1989 6
1990 5
1991 5
1995 1
1996 2
1997 2
1998 6
1999 2
2001 1
2003 1
2004 1
2007 2
2008 2
2009 4
2016 1
2017 1
2018 3
2020 3
2021 6
2022 8
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.
Masuda T, Miura S, Sato Y, Tachihara M, Bessho A, Nakamura A, Miyawaki T, Yoshimine K, Mori M, Shiraishi H, Hamai K, Haratani K, Maeda S, Tabata E, Kitagawa C, Tanizaki J, Imai T, Nogami S, Yamamoto N, Nakagawa K, Hattori N. Masuda T, et al. Among authors: hamai k. Sci Rep. 2023 Nov 13;13(1):19729. doi: 10.1038/s41598-023-45337-3. Sci Rep. 2023. PMID: 37957228 Free PMC article.
A new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study.
Tsubata Y, Hotta T, Hamai K, Furuya N, Yokoyama T, Saito R, Nakamura A, Masuda T, Hamaguchi M, Kuyama S, Honda R, Senoo T, Nakanishi M, Yamasaki M, Ishikawa N, Fujitaka K, Kubota T, Kobayashi K, Isobe T. Tsubata Y, et al. Among authors: hamai k. J Hematol Oncol. 2022 Apr 4;15(1):40. doi: 10.1186/s13045-022-01259-7. J Hematol Oncol. 2022. PMID: 35379309 Free PMC article.
Late onset bone marrow transplant nephropathy.
Oyama Y, Komatsuda A, Imai H, Ohtani H, Hamai K, Wakui H, Miura AB, Nakamoto Y. Oyama Y, et al. Among authors: hamai k. Intern Med. 1996 Jun;35(6):489-93. doi: 10.2169/internalmedicine.35.489. Intern Med. 1996. PMID: 8835602 Free article. Review.
Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer.
Watari N, Yamaguchi K, Terada H, Hamai K, Masuda K, Nishimura Y, Sakamoto S, Masuda T, Horimasu Y, Miyamoto S, Nakashima T, Iwamoto H, Shoda H, Ishikawa N, Fujitaka K, Miyazaki K, Miyata Y, Hamada H, Awai K, Hattori N. Watari N, et al. Among authors: hamai k. BMC Pulm Med. 2022 Jun 30;22(1):260. doi: 10.1186/s12890-022-02037-4. BMC Pulm Med. 2022. PMID: 35773658 Free PMC article.
Effect of baricitinib in patients with coronavirus disease 2019 and respiratory failure: A propensity score-matched retrospective cohort study.
Tanimoto T, Tada S, Fujita S, Hirakawa T, Matsumura M, Isoyama S, Ueno S, Hamai K, Tsuji N, Hirosawa H, Taniguchi T, Okamoto T, Omoto T, Kusunoki S, Maeda H, Ishikawa N. Tanimoto T, et al. Among authors: hamai k. Respir Investig. 2022 May;60(3):418-424. doi: 10.1016/j.resinv.2022.02.004. Epub 2022 Mar 7. Respir Investig. 2022. PMID: 35307364 Free PMC article.
Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1.
Masuda T, Fujitaka K, Suzuki T, Hamai K, Matsumoto N, Matsumura M, Isoyama S, Ueno S, Mito M, Yamaguchi K, Sakamoto S, Kawano R, Masuda K, Nishino R, Ishikawa N, Yamasaki M, Hattori N. Masuda T, et al. Among authors: hamai k. Thorac Cancer. 2022 Jun;13(11):1611-1618. doi: 10.1111/1759-7714.14428. Epub 2022 Apr 30. Thorac Cancer. 2022. PMID: 35488720 Free PMC article. Clinical Trial.
65 results